AQP4 is also expressed on syncytiotrophoblasts of the placenta, and symptoms like preeclampsia, intrauterine growth restriction, and stillbirth indicative of placental dysfunction are observed with increased frequency in AQP4-abspositive NMOSD (for review refer to [101]). Here, AQP4 is linked to fetal growth restriction.